Androchem
Toggle sidebar
ChemAesthetic Retatrutide 10mg vial kit

ChemAesthetic Retatrutide 10mg vial kit

£100.00

✓ Dispatched same or next working day · 2–3 day UK delivery

ChemAesthetic Retatrutide 10mg vial kit
Triple hormone receptor agonist peptide for metabolic research

Retatrutide (LY-3437943) is an experimental drug described as a triple glucagon hormone receptor agonist. It is investigated in research for multi‑receptor signalling across glucagon, GLP‑1 and GIP pathways.

• Dose: 10mg
• Format: lyophilised vial kit
• Brand: ChemAesthetic

For laboratory research use only. Not intended for human consumption or clinical application.

Focus Areas

  • No areas provided.

Legal Disclaimer

  • Supplied for research purposes only. Not for human consumption.
  • No advice is provided on its use due to legal restrictions.
  • Check legality for your jurisdiction before ordering.

Stacks well with

Commonly combined with ChemAesthetic Retatrutide 10mg vial kit in research protocols.

ChemAesthetic Retatrutide 30mg vial kit
ChemAesthetic Retatrutide 30mg vial kit
£150.00
MK-677 (Ibutamoren)
MK-677 (Ibutamoren)
£32.99

Research Profile

Retatrutide
LY3437943
Triple Agonist (GIP/GLP-1/Glucagon)
Half-life
168.0h
Typical Dose
1–12mg
Research Duration
24–48 wks
Anabolic Activity 1/10
Androgenic Risk 1/10
Suppression Risk 1/10

Ratings are based on published research data and are for informational purposes only.

Research Summary

Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors. The Eli Lilly Phase II trial (NEJM 2023) demonstrated up to 24.2% body weight reduction at 48 weeks — the highest published weight loss of any drug in human trials. Phase III is ongoing.

Compare this compound →